Integra Wound Matrix (Thin) has received 510(k) clearance from the United States Food and Drug Administration.
Integra Wound Matrix (Thin) is a collagen-glycosaminoglycan wound matrix that maintains and supports a healing environment for wound management. The company expects to begin a full-market release of the product in April.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
